Story perspectives

CAR T-Cell Therapy Shows Promise Against Alzheimer's in Mice

2/10/2026

Summary

Story summary

Researchers from the Weizmann Institute of Science and Washington University used CAR T-cell therapy for Alzheimer's disease and reduced amyloid-beta plaques and brain inflammation in mice.
The study, published in the Proceedings of the National Academy of Sciences (PNAS), was led by Ido Amit and Jonathan Kipnis.
The findings indicate CAR T technology could address other neurodegenerative diseases, such as ALS and Parkinson's.
Future studies will explore CAR T therapy for brain injury recovery and neural repair.

1 of 1

Story summary

Researchers from the Weizmann Institute of Science and Washington University used CAR T-cell therapy for Alzheimer's disease and reduced amyloid-beta plaques and brain inflammation in mice.
The study, published in the Proceedings of the National Academy of Sciences (PNAS), was led by Ido Amit and Jonathan Kipnis.
The findings indicate CAR T technology could address other neurodegenerative diseases, such as ALS and Parkinson's.
Future studies will explore CAR T therapy for brain injury recovery and neural repair.